REFERENCES
- Berg KJ, Holdaas H, Endresen L, Fauchald P, Hartmann A, Pran T, Solbu D. Effects of isradipine on renal function in cyclosporin-treated renal transplanted patients. Nephrol Dial Transpl 1991; 6: 725–730.
- Chan L, Schrier RW. Effects of calcium channel blockers on renal function. Ann Rev Med 1990; 41: 289–302.
- Dawidson I, Rooth P, Fry WR, Sandor Z, Willms C, Coorpender L, Alway C, Reisch J. Prevention of acute cyclosporine-induced renal blood flow inhibition and improved immunosuppression with verapamil. Transplantation 1989; 48: 575–580.
- Dawidson I, Rooth P, Alway C, Dulzo T, Palmer B, Lu C, Peters P, Sagalowsky A, Sandor Z. Verapamil prevents posttransplant delayed function and cyclosporine A nephrotoxicity. Transplant Proc 1990; 22: 1379–1380.
- Dawidson I, Rooth P, Lu C, Sagalowsky A, Diller K, Palmer B, Peters P, Risser R, Sandor Z, Seney F. Verapamil improves the outcome after cadaver renal transplantation. J Am Soc Nephrol 1991; 2: 983–990.
- Epstein M. Calcium antagonists and renal protection. Arch Intern Med 1992; 152: 1573–1584.
- Frei U, Margreiter R, Harms A, Bösmüller C, Neumann KH, Viebahn R, Gubernatis G, Wonigeit K, Pichlmayr R. Preoperative graft perfusion with a calcium antagonist improves initial function: preliminary results of a prospective randomized trial in 110 kidney recipients. Transplant Proc 1987; 19: 3539–3541.
- Frei UHarms ABakovic-Alt B, Pichlmayr R, Koch KM. Calcium channel blockers for kidney protection. J Cardiovasc Pharm 1990; 16 (Suppl 6): S11–S15.
- Harper SJ, Moorhouse J, Veitch PS, Horsburgh T, Walls J, Bell PRF, Donnelly PK, Feehally J. Nifedipine improves immediate, and 6- and 12-months graft function in cyclosporin A (CyA) treated renal allograft recipients. Transplant Int 1992; 5 (Suppl 1): S69–S72.
- Howard RL, Shapiro JI, Babcock S, Chan L. The effect of calcium channel blockers on the cyclosporine dose requirement in renal transplant patients. Renal Failure 1990; 12: 89–92.
- Korb S, Albornoz G, Brems W, Ali A, Light JA. Verapamil pretreatment of hemodynamically unstable donors prevents delayed graft function post-transplant. Transplant Proc 1989; 21: 1236–1238.
- Ljung B, Nordlander M. Pharmacodynamic properties of felodipine. Drugs 1987; 34 (Suppl 3): 7–15.
- Morales JM, Andrés A, Alvarez C, Prieto C, Ortuño B, Ortuño T, Paternina ER, Hernandez Poblete G, Praga M, Ruilope LM, Rodicio JL. Calcium channel blockers and early cyclosporine nephrotoxicity after renal transplantation: A prospective randomized study. Transplant Proc 1990; 22: 1733–1735.
- Pritza DR, Biermann MH, Hammeke MD. Acute toxic effects of sustained-release verapamil in chronic renal failure. Arch Intern Med 1991; 151: 2081–2084.
- Struyker-Boudier HAJ, Smits JFM, De Mey JGR. The pharmacology of calcium channel antagonists: A review. J Cardiovasc Pharmacol 1990; 15 (Suppl 4): S1–S10.
- Sôrensen SS, Skovbon H, Eiskjær H, Thomsen K, Pedersen EB. Effect of felodipine on renal haemodynamics and tubular sodium handling in cyclosporin-treated renal transplant recipients. Nephrol Dial Transplant 1992; 7: 69–78.
- Wagner K, Albrecht S, Neumayer H-H. Prevention of posttransplant acute tubular necrosis by the calcium antagonist diltiazem: A prospective randomized study. Am J Nephrol 1987; 7: 287–291.